elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28252207-81638A0E-8BDB-42A3-B783-24B9ED29381C
Q28252207-81638A0E-8BDB-42A3-B783-24B9ED29381C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-81638A0E-8BDB-42A3-B783-24B9ED29381C
Risks and benefits of infliximab for the treatment of Crohn's disease
P577
Q28252207-81638A0E-8BDB-42A3-B783-24B9ED29381C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-81638A0E-8BDB-42A3-B783-24B9ED29381C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
58660efd1d48394ce5568d0d2680f00c3696d4f3
P577
2006-07-14T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
3645f85c6d248f064c47767e2ab42be5